Adam J Prus

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Topics

Neuropathic Pain

Major Depressive Disorder

Top Venues

Experimental and clinical psychopharmacology

Drug development research

This page only lists publications with an associated author ORCID identifier.

Publications

Adam J Prus, Madeline T Van Fossen, Alexandria N Iannucci, Alexia G Dalton, Joshua N Prete
Discriminative stimulus properties of two training doses of gabapentin in rats: Substitution by pregabalin, diazepam, and pentobarbital. Experimental and clinical psychopharmacology (2024)
Adam J Prus, Madeline T Van Fossen, Alexandria N Iannucci, Alexia G Dalton, Joshua N Prete
Discriminative stimulus properties of two training doses of gabapentin in rats: Substitution by pregabalin, diazepam, and pentobarbital. Experimental and clinical psychopharmacology 32 (4) (2024)
Adam J Prus, Madeline T Van Fossen, Alexandria N Iannucci, Alexia G Dalton, Joshua N Prete
Discriminative stimulus properties of two training doses of gabapentin in rats: Substitution by pregabalin, diazepam, and pentobarbital. Experimental and clinical psychopharmacology (2024)
Adam J Prus, Madeline T Van Fossen, Alexandria N Iannucci, Alexia G Dalton, Joshua N Prete
Discriminative stimulus properties of two training doses of gabapentin in rats: Substitution by pregabalin, diazepam, and pentobarbital. Experimental and clinical psychopharmacology 32 (4) (2024)
Adam J Prus, Madeline T Van Fossen, Alexandria N Iannucci, Alexia G Dalton, Joshua N Prete
Discriminative stimulus properties of two training doses of gabapentin in rats: Substitution by pregabalin, diazepam, and pentobarbital. Experimental and clinical psychopharmacology 32 (4) (2024)
Lawrence M Carey, Remington J Rice, Adam J Prus
The Neurotensin NTS1 Receptor Agonist PD149163 Produces Antidepressant-Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant Drugs. Drug development research 78 (5) (2017)